Construction and Validation of Dementia Care Management Competency
Construction and Validation of Dementia Care Management Competency: From Curriculum Integration to Outcome Evaluation
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Huei-Ling Huang, PhD
- Phone Number: 5803 +886-3-2118999
- Email: hlhuang@gw.cgust.edu.tw
Study Locations
-
-
-
Taoyuan, Taiwan, 333
- Recruiting
- Chang Gung University of Science and Technology
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
(1)Be at least 20 years old.
(2)The students are freshmen majoring in the Department of Gerontology and Health Care Management, and taking the course on Dementia care.
(3)Before taking the course on Dementia care, have taken courses on basic geriatric nursing.
(4)voluntary participation
Exclusion Criteria:
- The students who suspension of schooling.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: conventional teaching group
conventional teaching methods
|
The conventional teaching group will receive only traditional classroom teaching course programs.
Other Names:
|
|
Experimental: curriculum integration Group
The curriculum integration group will receive two intervention phases, including an innovation-integrated curriculum for dementia care and an innovation-integrated curriculum for care management with Entrustable Professional Activities (EPAs) to guide learning and assessment of competency performance to equip students with dementia care management competency.
|
The curriculum integration group will receive two intervention phases, including an innovation-integrated curriculum for dementia care and an innovation-integrated curriculum for care management with Entrustable Professional Activities (EPAs), lectures, Situated Simulation Learning, Team-based learning, and Objective Structured Clinical Examination(OSCE).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Demographic data of student
Time Frame: The investigators will collect demographic data of students on the day before the start date of the intervention.
|
Include age, gender, education level, areas of studying, etc.
|
The investigators will collect demographic data of students on the day before the start date of the intervention.
|
|
Dementia Care Professional Competency Assessment Scale
Time Frame: T0(Baseline), T1(Immediately after the intervention), T2(3 months after the intervention).
|
|
T0(Baseline), T1(Immediately after the intervention), T2(3 months after the intervention).
|
|
Problem solving, Teamwork Competency Assessment Scale
Time Frame: T0(Baseline), T1(Immediately after the intervention), T2(3 months after the intervention).
|
|
T0(Baseline), T1(Immediately after the intervention), T2(3 months after the intervention).
|
|
Learning Satisfaction Scale
Time Frame: Immediately after the intervention.
|
|
Immediately after the intervention.
|
|
Performance in a summative OSCE test (OSCE scores)
Time Frame: Immediately after the intervention.
|
|
Immediately after the intervention.
|
|
Qualitative interview
Time Frame: The investigators will conduct qualitative interviews using focus groups 3 months after the intervention.
|
Conduct qualitative interviews with the curriculum integration group students, focusing on the effectiveness of the curriculum integration.
|
The investigators will conduct qualitative interviews using focus groups 3 months after the intervention.
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Chair: Huei-Ling Huang, PhD, Chang Gung University of Science and Technology
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- NSTC 112-2410-H-255 -006 -MY2
- NMRPF3N0081 (Other Identifier: Chang Gung University of Science and Technology)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.